Avanafil

CAS No. 330784-47-9

Avanafil ( TA1790;TA 1790;TA-1790 )

Catalog No. M14101 CAS No. 330784-47-9

A potent and highly selective PDE5 inhibitor (IC50=5.2 nM) for erectile dysfunction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 42 In Stock
50MG 52 In Stock
100MG 85 In Stock
200MG 102 In Stock
500MG 125 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Avanafil
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and highly selective PDE5 inhibitor (IC50=5.2 nM) for erectile dysfunction.
  • Description
    A potent and highly selective PDE5 inhibitor (IC50=5.2 nM) for erectile dysfunction; shows no significant effect on PDE1, PDE6 and PDE11.Sexual Dysfunction Approved
  • Synonyms
    TA1790;TA 1790;TA-1790
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE5
  • Research Area
    Endocrinology
  • Indication
    Sexual Dysfunction

Chemical Information

  • CAS Number
    330784-47-9
  • Formula Weight
    483.95
  • Molecular Formula
    C23H26ClN7O3
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(C1=CN=C(N2[C@H](CO)CCC2)N=C1NCC3=CC=C(OC)C(Cl)=C3)NCC4=NC=CC=N4
  • Chemical Name
    5-Pyrimidinecarboxamide, 4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kotera J, et al. J Urol. 2012 Aug;188(2):668-74.
2. Limin M, et al. Expert Opin Investig Drugs. 2010 Nov;19(11):1427-37.
3. Wang R, et al. J Sex Med. 2012 Aug;9(8):2122-9.
molnova catalog
related products
  • Autotaxin-IN-3

    Autotaxin-IN-3 is an Autotaxin(ATX) inhibitor (IC50: 2.4 nM) sourced from patent WO2018212534A1 (compound 33).

  • Trapidil

    Trapidil is a vasodilator, is an antiplatelet drug with specific platelet-derived growth factor.

  • ITI214 free base

    ITI-214 is a potent, selective phosphodiesterase 1 (PDE1) inhibitor with Ki of 58 pM.